Cargando…
In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea
Ceftazidime-avibactam (CAZ-AVI) and aztreonam-avibactam (AZT-AVI) are novel antibiotic combinations active against multidrug-resistant Gram-negative pathogens. This study aimed to evaluate their in vitro activities and inoculum effects in carbapenem-resistant Enterobacterales (CRE), including carbap...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765481/ https://www.ncbi.nlm.nih.gov/pubmed/33334045 http://dx.doi.org/10.3390/antibiotics9120912 |
_version_ | 1783628500277657600 |
---|---|
author | Kim, Taeeun Lee, Seung Cheol Bae, Moonsuk Sung, Heungsup Kim, Mi-Na Jung, Jiwon Kim, Min Jae Kim, Sung-Han Lee, Sang-Oh Choi, Sang-Ho Kim, Yang Soo Chong, Yong Pil |
author_facet | Kim, Taeeun Lee, Seung Cheol Bae, Moonsuk Sung, Heungsup Kim, Mi-Na Jung, Jiwon Kim, Min Jae Kim, Sung-Han Lee, Sang-Oh Choi, Sang-Ho Kim, Yang Soo Chong, Yong Pil |
author_sort | Kim, Taeeun |
collection | PubMed |
description | Ceftazidime-avibactam (CAZ-AVI) and aztreonam-avibactam (AZT-AVI) are novel antibiotic combinations active against multidrug-resistant Gram-negative pathogens. This study aimed to evaluate their in vitro activities and inoculum effects in carbapenem-resistant Enterobacterales (CRE), including carbapenemase-producing (CP)-CRE and non-CP-CRE. A total of 81 independent clinical isolates of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae were collected. CAZ-AVI and AZT-AVI minimal inhibitory concentrations (MICs) were evaluated by broth microdilution using standard and high inocula. The inoculum effect was defined as an ≥8-fold increase in MIC with high inoculum. Phenotypic determination of β-lactam resistance mechanism and PCR for carbapenemase genes were performed. Of the 81 CRE isolates, 35 (43%) were CP-CRE. Overall, 73% of the isolates were susceptible to CAZ-AVI, and 95% had low AZT-AVI MICs (≤8 µg/mL). The MIC(50/)MIC(90)s of CAZ-AVI and AZT-AVI were 4/≥512 µg/mL and 0.5/4 µg/mL, respectively. CAZ-AVI was more active against non-CP-CRE than against CP-CRE (susceptibility 80% vs. 63%, p = 0.08; MIC(50)/MIC(90), 2/16 μg/mL vs. 4/≥512 μg/mL), whereas AZT-AVI was more active against CP-CRE (MIC(50)/MIC(90), 0.25/1 μg/mL vs. 0.5/8 μg/mL). All four isolates with high AZT-AVI MIC (≥16 μg/mL) were resistant to CAZ-AVI, but only 18% (4/22) of CAZ-AVI-resistant isolates had high AZT-AVI MIC. The rates of the inoculum effect for CAZ-AVI and AZT-AVI were 18% and 47%, respectively (p < 0.001). Interestingly, the frequency of the AZT-AVI inoculum effect was higher in K. pneumoniae than E. coli (64% vs. 8%, p < 0.001). AZT-AVI is more active against CRE than CAZ-AVI, even in CP-CRE and CAZ-AVI-resistant isolates. The presence of a substantial inoculum effect may contribute to clinical failure in high-inoculum infections treated with AZT-AVI. |
format | Online Article Text |
id | pubmed-7765481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77654812020-12-27 In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea Kim, Taeeun Lee, Seung Cheol Bae, Moonsuk Sung, Heungsup Kim, Mi-Na Jung, Jiwon Kim, Min Jae Kim, Sung-Han Lee, Sang-Oh Choi, Sang-Ho Kim, Yang Soo Chong, Yong Pil Antibiotics (Basel) Article Ceftazidime-avibactam (CAZ-AVI) and aztreonam-avibactam (AZT-AVI) are novel antibiotic combinations active against multidrug-resistant Gram-negative pathogens. This study aimed to evaluate their in vitro activities and inoculum effects in carbapenem-resistant Enterobacterales (CRE), including carbapenemase-producing (CP)-CRE and non-CP-CRE. A total of 81 independent clinical isolates of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae were collected. CAZ-AVI and AZT-AVI minimal inhibitory concentrations (MICs) were evaluated by broth microdilution using standard and high inocula. The inoculum effect was defined as an ≥8-fold increase in MIC with high inoculum. Phenotypic determination of β-lactam resistance mechanism and PCR for carbapenemase genes were performed. Of the 81 CRE isolates, 35 (43%) were CP-CRE. Overall, 73% of the isolates were susceptible to CAZ-AVI, and 95% had low AZT-AVI MICs (≤8 µg/mL). The MIC(50/)MIC(90)s of CAZ-AVI and AZT-AVI were 4/≥512 µg/mL and 0.5/4 µg/mL, respectively. CAZ-AVI was more active against non-CP-CRE than against CP-CRE (susceptibility 80% vs. 63%, p = 0.08; MIC(50)/MIC(90), 2/16 μg/mL vs. 4/≥512 μg/mL), whereas AZT-AVI was more active against CP-CRE (MIC(50)/MIC(90), 0.25/1 μg/mL vs. 0.5/8 μg/mL). All four isolates with high AZT-AVI MIC (≥16 μg/mL) were resistant to CAZ-AVI, but only 18% (4/22) of CAZ-AVI-resistant isolates had high AZT-AVI MIC. The rates of the inoculum effect for CAZ-AVI and AZT-AVI were 18% and 47%, respectively (p < 0.001). Interestingly, the frequency of the AZT-AVI inoculum effect was higher in K. pneumoniae than E. coli (64% vs. 8%, p < 0.001). AZT-AVI is more active against CRE than CAZ-AVI, even in CP-CRE and CAZ-AVI-resistant isolates. The presence of a substantial inoculum effect may contribute to clinical failure in high-inoculum infections treated with AZT-AVI. MDPI 2020-12-15 /pmc/articles/PMC7765481/ /pubmed/33334045 http://dx.doi.org/10.3390/antibiotics9120912 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kim, Taeeun Lee, Seung Cheol Bae, Moonsuk Sung, Heungsup Kim, Mi-Na Jung, Jiwon Kim, Min Jae Kim, Sung-Han Lee, Sang-Oh Choi, Sang-Ho Kim, Yang Soo Chong, Yong Pil In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea |
title | In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea |
title_full | In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea |
title_fullStr | In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea |
title_full_unstemmed | In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea |
title_short | In Vitro Activities and Inoculum Effects of Ceftazidime-Avibactam and Aztreonam-Avibactam against Carbapenem-Resistant Enterobacterales Isolates from South Korea |
title_sort | in vitro activities and inoculum effects of ceftazidime-avibactam and aztreonam-avibactam against carbapenem-resistant enterobacterales isolates from south korea |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765481/ https://www.ncbi.nlm.nih.gov/pubmed/33334045 http://dx.doi.org/10.3390/antibiotics9120912 |
work_keys_str_mv | AT kimtaeeun invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT leeseungcheol invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT baemoonsuk invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT sungheungsup invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT kimmina invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT jungjiwon invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT kimminjae invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT kimsunghan invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT leesangoh invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT choisangho invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT kimyangsoo invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea AT chongyongpil invitroactivitiesandinoculumeffectsofceftazidimeavibactamandaztreonamavibactamagainstcarbapenemresistantenterobacteralesisolatesfromsouthkorea |